Heading to the Clinical Trials in Oncology East Coast conference in Boston? Don't miss Aixial Group at Booth #16! Laura and Shawn look forward to discussing the challenges in your oncology trials and exploring how we can help you overcome them. With over 300 oncology studies completed, our experienced team understand the complexities of oncology trials and can ensure timely delivery. Stop by our booth or reach out to us now to discuss your specific needs: [email protected] #AixialGroup #CRO #ArenaOncologyEastCoast #Conference
AIXIAL GROUP’s Post
More Relevant Posts
-
Did you miss our latest webinar? Not to worry! You can still watch the recording of our webinar and learn more about the challenges associated with central image reading in oncology clinical trials, how they impact trial results and their root for better drug efficacy evaluation. You can watch the webinar here 👉 https://lnkd.in/eD3DDijE #MedianWebinar #oncologytrials
-
Is your site considering phase 1 oncology trials? SCRS has a guide that outlines several major considerations a site should explore when considering these types of trials. Access it here ⇢ https://lnkd.in/gBqrX2TX
-
-
Is your site considering phase 1 oncology trials? SCRS has a guide that outlines several major considerations a site should explore when considering these types of trials. Access it here ⇢ https://lnkd.in/gBqrX2TX
-
-
Oncology clinical trials are uniquely complex. Maximizing your #eCOA can help. Download our newest infographic to stay up-to-date on the latest eCOA oncology clinical trial insights here: https://hubs.ly/Q02qx-dQ0
-
Director of Precision Oncology, Cincinnati Cancer Advisors. APSHO Vice President (Advanced Practitioner Society for Hematology and Oncology). APSHO BOD. Medical Speaker. Consultant. Theme Park Writer. Ski Patroller.
Wow. It seems like forever ago that we wrote this paper - “A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding”. The topic is increasingly important today! Thanks Dr. Jazieh and IHCI for inviting me to this panel discussion! https://lnkd.in/gzq6gVih
-
Preparing for #ESMO: Thrilled to be attending the prestigious ESMO (European Society for Medical Oncology) conference in Madrid this year. ESMO is a leading event in the field of medical oncology that brings together industry experts, clinicians, researchers, and pharma professionals, offering an unparalleled opportunity to exchange knowledge and keep up with the latest advancements in the field of cancer treatment. This conference holds immense value for me and our organization. It allows us to stay at the forefront of the rapidly evolving oncology landscape and foster collaborations with key stakeholders in the industry. Attending ESMO is a testament to Simbec Orion's commitment to advancing cancer research and our dedication to improving patient outcomes. Our team will be actively participating in discussions about our latest research findings, and engaging in networking opportunities with like-minded professionals from across the globe. This conference provides an excellent platform to showcase our expertise and innovation in clinical research, particularly in the areas of early-phase oncology trials, biomarkers, and novel therapeutic interventions. By staying connected to the latest breakthroughs and emerging trends in the fast-paced world of oncology, we can better serve our clients and ultimately contribute to advancements in cancer treatment. I am looking forward to building connections, exchanging ideas, and exploring potential collaborations that will drive Simbec Orion's mission of accelerating drug development and ultimately benefiting patients worldwide. If you are attending ESMO and would like to connect, I would be delighted to meet and discuss how we can work together to make a tangible impact in the fight against cancer. Stay tuned for exciting updates during the conference! 🎉 #ESMO2023 #Oncology #ClinicalResearch #MedicalOncology #CancerResearch #SimbecOrion #BusinessDevelopment #Networking #Collaboration
With almost 3 decades of experience in the delivery of oncology clinical trials, including rare oncology, we understand how to manage these complex studies. Our teams design and conduct a comprehensive portfolio of trials, from First in Human, Phase I/II adaptive trials, through to Phase III studies. Continually striving for transparent and honest partnerships with our clients, we are supported by a world-leading, independent oncology advisory board who are ready to guide your program toward your target exit strategy, be it asset sale or registration. Romillie Cruz, MD and Alain Thibault MD are excited to be attending #ESMO23 Contact us to set up a meeting in Madrid https://bit.ly/3tcSBot
Leverage 3 decades of oncology trial expertise: meet us at ESMO 2023
https://vimeo.com/
-
Take a look into the current clinical pathways landscape with our just released 2023 Oncology Clinical Pathways Report. To read our analysis and understand the implications these issues have on your oncology business, contact Sara Stewart to see how you can access the full report. https://lnkd.in/gDkSEGP4 #oncologyclinicalpathways #pathwaysreport #marketaccessinsights #marketaccess
-
-
Advancing Clinical Product Development in the Pan-Pacific Region U.S. FDA, TFDA, and NMPA Regulatory and Approval Strategies MRCTs GMPs QSRs AI Software SaMD
In the past two days, I have engaged in in-depth discussions with industry experts about the progress, trends, and challenges for the development of immuno oncology! The dedication of Amarex to supporting these experts in delivering groundbreaking treatments to patients is truly motivating. #immunooncologysummit2023 #AmarexClinicalResearch #clinicaltrials #fdaapproval
-
-
🔍 Searching for the most advanced endpoint collection technologies for your oncology trials? Look no further! Clario's updated Oncology Trial Solutions Portfolio has you covered. Dive into the details in the link below! #OncologyResearch #ClinicalTrials
Clario Reveals Updated Oncology Trial Solutions Portfolio: The Industry's Widest Range of Endpoint Collection Technologies | Clario
clario.shp.so
-
🔍 Searching for the most advanced endpoint collection technologies for your oncology trials? Look no further! Clario's updated Oncology Trial Solutions Portfolio has you covered. Dive into the details in the link below! #OncologyResearch #ClinicalTrials
Clario Reveals Updated Oncology Trial Solutions Portfolio: The Industry's Widest Range of Endpoint Collection Technologies | Clario
clario.shp.so
